Q Cancer researchers claim 'extraordinary results' using T-cell therapy ‘This is unprecedented’ says researcher after more than half of terminally ill blood cancer patients experienced complete remission in early clinical trials Tuesday 16 February 2016 https://www.theguardian.com/science...sults-t-cell-therapy-research-clinical-trials ... ... In the most promising study, about 35 patients with ALL were treated with Cars-modified T-cells; 94% went into remission, though symptoms could reappear. More than 40 patients with lymphoma have also been treated, with remission rates of more than 50%. In a group with non-Hodgkin’s lymphoma, there was evidence of diminished cancer symptoms in more than 80% of cases. “Much like chemotherapy and radiotherapy, it’s not going to be a save-all,” Riddell said of the new therapy, adding: “I think immunotherapy has finally made it to a pillar of cancer therapy.” A paper on the ALL research is currently under review and pending publication. UQ
ZIOP - ZIOPHARM Oncology (NASDAQ) 6.12 +0.52 (9.29%) 16 Feb 4:00pm GMT-5 - Disclaimer 6.25 +0.13 (2.12%) After Hours Q http://finance.yahoo.com/mb/ZIOP/ UBS Group adds 369,240 ZIOP shares 12 hours ago by before_its_news 2/0 3 2 hours 25 minutes ago by before_its_news Legg Mason adds 840,299 ZIOP shares 12 hours ago by before_its_news 2/0 3 2 hours 25 minutes ago by before_its_news State Street picks up almost a MILLION ZIOP shares 7 hours ago by before_its_news 3/0 1 2 hours 26 minutes ago by before_its_news Goldman Sachs adds almost 300,000 shares of ZIOP 7 hours ago by before_its_news 3/0 1 2 hours 26 minutes ago by before_its_news Arrowstreet Capital establishes new position, buys over 600,000 shares of ZIOP 7 hours ago by before_its_news 3/0 1 2 hours 26 minutes ago by before_its_news UQ
yea, this goes both ways. I tried investing in NantKwest several times since it came public with no success what so ever, Lots of people bought it at $32 around the IPO and now it trades at $7. Its been falling hard since the IPO and then fell another 41% in January 2016 after lockup expired. I figure to buy some once it falls below $5...that area of biotech seems very much in the distant future and they wheel out a few Very small studies with some Very few people and a couple have success...they wheel out these stories every once in a while to kick the success can down the road...I think around 2020-2025 this will be something to re-visit.